Advancing Stem Cell Therapies – From Research to Reality
Thursday, May 8th 2025
Cell-based therapies are transforming modern medicine, offering new solutions for hard-to-treat diseases.
However, translating research into effective treatments requires overcoming key challenges, from understanding stem cell and immune therapy biology to scaling manufacturing and navigating regulations.
Join us for a focused half-day seminar with leading experts as we explore the latest advancements and chart a path toward bringing cell-based therapies into clinical practice.
Attendance is free, but we kindly ask that you sign up for the symposium at before May 6th.
Program
12.30-12.35 Welcome and introduction
Stine Rønholt, LEO Foundation Center for Cutaneous Drug Delivery / Danish Pharmaceutical Society & Lasse Saaby, Bioneer A/S / Department of Pharmacy, KU
12.35-13.05 Advancements in Preclinical and Clinical Stem Cell Therapies for the Central Nervous System
Agnete Kirkeby, Assoc. Prof., University of Copenhagen
13.05-13.35 Translating Knowledge on Stem Cells and Tissue Regeneration into Clinical Practice
Ditte Caroline Andersen, Professor, SDU
13.35-14.05 Mesenchymal Stromal Cells to Treat Patients with Non-Ischaemic Heart Failure
Morten Juhl Nørgaard, Cardiology Stem Cell Centre, Rigshospitalet
14:05-14:25 Coffee and refreshments
14.25-14:55 Advancing Cancer Immunotherapy: 25 Years of Progress in T-Cell Based Therapies
Inger Marie Svane, Professor, Director, National Center for Cancer Immune Therapy, Herlev Hospital
14.55-15.25 Elucidating the Functional Consequences of Contact Between Macrophages and T Cells
Kolade Adebowale, Assistant Prof. University of San Diego
15.25-15.55 Making stem cells available for therapy
Anette Ekblond, Director of R&D, Cell2Cure
15:55-16:10 Coffee and refreshments
16:10-16.40 Lessons Learned from Development of Stem Cell-based Therapies
Tanja Villumsen, Head of Clinical Supplies, Cell Therapy R&D, Novo Nordisk
16.40-17.10 Navigating the Way from Laboratory to Human Testing in Stem Cell-based Therapies
Thomas Hassing Ronøe Carlsen, CEO Novo Nordisk Foundation Cellerator P/S
17.10-17.40 Charting the Course: Regulatory Frameworks in Cell Therapy Development
Pernille Sterling, Danish Medical Agency
17.40-17.45 Wrap up
Hanne Mørck Nielsen, Danish Pharmaceutical Society
Details
Start:
Thursday, May 8th at 12:30
End:
Thursday, May 8th at 17:45
Location:
Auditorium 4, Department of Pharmacy, KU,
Universitetsparken 2, 2100 CPH O
Register before:
Tuesday, May 6th 2025
